It is with great pleasure that we invite you to attend the 3rd International Congress on Brain Health Innovations & Technologies (Brain2026), held 4–5 May 2026 in Tel Aviv.
A dynamic two-day conference, Brain2026 spans the full spectrum of brain science and health and strengthens collaboration across the wider brain community. Israel’s innovation ecosystem provides an ideal setting for the congress.
Brain2026 brings together physicians and neuroscientists alongside innovators, start-ups and leaders from the biopharma, med-tech, and brain-tech sectors. The meeting provides a forum to review clinical and scientific developments and to explore therapeutic and diagnostic advances emerging from clinical research and trials within a multidisciplinary setting.
As data-driven approaches and AI continue to transform brain science, these directions will be reflected across multiple sessions throughout the program.
This year’s program will highlight new approaches shaping the future of brain research, diagnosis, and care, around several key areas of development:
Brain Health, Prevention & Vascular Science- Progress in stroke and cerebral small-vessel disease, brain aging, metabolic risk, and risk-reduction strategies aimed at preserving and improving brain health.
Cognitive, Behavioral & Mental Health Innovations- Advances in cognitive and behavioral disorders, diagnostic strategies, digital biomarkers, AI-based assessment tools, disease-modifying therapies, and mental health therapeutics.
AI, Brain Technology & Advanced Diagnostics– Developments in AI-assisted brain sciences, digital health and wearables, neuro-monitoring, neurosurgical advances, technologies for TBI and next-generation neuro-rehabilitation.
Innovations in Neurological Therapeutics– Advances in neurodegenerative and movement disorders, immune-mediated neurological disease, migraine therapeutics and epilepsy treatment, monitoring, and neuromodulation
We invite you to join us at Brain2026, engage with colleagues from multiple disciplines and contribute to the next phase of brain research and care.
Congress Chair
